Digenic heterozygous HNF1A and HNF4A mutations in two siblings with childhood-onset diabetes

Pediatric Diabetes

Volumn 14, Issue 7, 2013, Pages 535-538

  Shankar, Roopa Kanakatti ^a   Ellard, Sian ^b   Standiford, Debra ^a   Pihoker, Catherine ^c   Gilliam, Lisa K ^d   Hattersley, Andrew ^b   Dolan, Lawrence M ^a  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF EXETER   (United Kingdom)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

HNF1A; HNF4A; MODY; Youth

Indexed keywords

GLIPIZIDE; HEPATOCYTE NUCLEAR FACTOR 1ALPHA; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; PIG INSULIN;

ADOLESCENT; ARTICLE; CASE REPORT; CHILDHOOD DISEASE; DIABETES MELLITUS; DRUG DOSE TITRATION; FEMALE; FOLLOW UP; FRAMESHIFT MUTATION; GENETIC SCREENING; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; HETEROZYGOTE; HUMAN; HYPERGLYCEMIA; INSULIN TREATMENT; INSULINOMA; ORAL GLUCOSE TOLERANCE TEST; PATHOGENICITY; POLYDIPSIA; POLYURIA; PRIORITY JOURNAL;

HNF1A; HNF4A; MODY; YOUTH;

ADOLESCENT; BLOOD GLUCOSE; CHILD; DIABETES MELLITUS, TYPE 2; FEMALE; HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; HEPATOCYTE NUCLEAR FACTOR 4; HUMANS; MALE; MIDDLE AGED; SIBLINGS; SULFONYLUREA COMPOUNDS;

EID: 84886641356     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12018     Document Type: Article

References (16)

1. Fajans SS, Bell GI, Polonsky KS. Molecular mechanisms and clinical pathophysiology of maturity-onset diabetes of the young. N Engl J Med 2001: 345: 971-980.
2. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue KC. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatr Diabetes 2009: 10 (Suppl. 12): 33-42.
3. Forlani G, Zucchini S, Di Rocco A et al. Double heterozygous mutations involving both HNF1A/MODY3 and HNF4A/MODY1 genes: a case report. Diabetes Care 2010: 33: 2336-2338.
4. Beijers HJBH, Losekoot M, Odink RJ, Bravenboer B. Hepatocyte nuclear factor (HNF)1A and HNF4A substitution occurring simultaneously in a family with maturity-onset diabetes of the young. Diabet Med 2009: 26: 1172-1174.
5. Ellard S, Colclough K. Mutations in the genes encoding the transcription factors hepatocyte nuclear factor 1 alpha (HNF1A) and 4 alpha (HNF4A) in maturity-onset diabetes of the young. Hum Mutat 2006: 27: 854-869.
6. Colclough K, Bellanne-Chantelot C, Saint-Martin C, Flanagan SE, Ellard S. Mutations in the Genes Encoding the Transcription Factors Hepatocyte Nuclear Factor 1 Alpha (HNF1A) and 4 Alpha (HNF4A) in Maturity-Onset Diabetes of the Young (MODY) and Hyperinsulinaemic Hypoglycaemia. Hum Mutat 2013: Epub
7. Flanagan SE, Kapoor RR, Mali G et al. Diazoxide-responsive hyperinsulinemic hypoglycemia caused by HNF4A gene mutations. Eur J Endocrinol 2010: 162: 987-992.
8. Furuta H, Iwasaki N, Oda N et al. Organization and partial sequence of the hepatocyte nuclear factor-4 alpha/MODY1 gene and identification of a missense mutation, R127W, in a Japanese family with MODY. Diabetes 1997: 46: 1652-1657.
9. Lausen J, Thomas H, Lemm I et al. Naturally occurring mutations in the human HNF4alpha gene impair the function of the transcription factor to a varying degree. Nucleic Acids Res 2000: 28: 430-437.
10. Navas MA, Munoz-Elias EJ, Kim J, Shih D, Stoffel M. Functional characterization of the MODY1 gene mutations HNF4(R127W), HNF4(V255M), and HNF4(E276Q). Diabetes 1999: 48: 1459-1465.
11. Yang Q, Yamagata K, Yamamoto K et al. R127W-HNF-4alpha is a loss of function mutation but not a rare polymorphism and causes Type II diabetes in a Japanese family with MODY1. Diabetologia 2000: 43: 520-524.
12. Lango Allen H, Johansson S, Ellard S et al. Polygenic risk variants for type 2 diabetes susceptibility modify age at diagnosis in monogenic HNF1A diabetes. Diabetes 2010: 59: 266-271.
13. Stride A, Shepherd M, Frayling TM, Bulman MP, Ellard S, Hattersley AT. Intrauterine hyperglycemia is associated with an earlier diagnosis of diabetes in HNF-1alpha gene mutation carriers. Diabetes Care 2002: 25: 2287-2291.
14. Bellanne-Chantelot C, Carette C, Riveline JP et al. The type and the position of HNF1A mutation modulate age at diagnosis of diabetes in patients with maturity-onset diabetes of the young (MODY)-3. Diabetes 2008: 57: 503-508.
15. Shepherd M, Shields B, Ellard S, Rubio-Cabezas O, Hattersley AT. A genetic diagnosis of HNF1A diabetes alters treatment and improves glycaemic control in the majority of insulin-treated patients. Diabet Med 2009: 26: 437-441.
16. Pearson ER, Pruhova S, Tack CJ et al. Molecular genetics and phenotypic characteristics of MODY caused by hepatocyte nuclear factor 4alpha mutations in a large European collection. Diabetologia 2005: 48: 878-885.